Legend to double Carvykti production as it targets blockbuster status 

Unlocking manufacturing capacity will be key for Legend Biotech and Johnson and Johnson in achieving their goal of reaching “blockbuster status” for Carvykti in 2025, CEO Ying Huang said. The companies were close to reaching ...

Related Posts

AbbVie finally enters obesity race with $350M upfront f...

Mar 3, 2025  0

Mineralys aims to raise $250M; Coherus discloses layoffs

Mar 11, 2025  0

Eli Lilly inks $630M deal for Phase 1 MASH candidate

Feb 10, 2025  0

Comments

Name

Email

Comment

Post Comment